Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Atomo Diagnostics.
RELATED STOCKHEAD STORIES
News
Last Orders: What you might have missed on the ASX today
News
Bhavdip143 just told us why Twitter banned him; pledges to keep posting
News
These ASX stocks are surging (and falling) on the Pfizer vaccine news
IPO Watch
IPO Watch: Doctor Care Anywhere set to join the ASX telehealth ranks next month
Health & Biotech
COVID has opened up potentially lucrative opportunities for these Aussie microcaps
IPO Watch
Here’s how 2020’s ASX IPOs have performed and who’s joining them later this year
Health & Biotech
COVID-19 testing will last for ‘several years not several months’
Experts
Scopo’s health powerplays: quick vaccine hits and cheap buys
Health & Biotech
Another two ASX stocks enter the race for faster COVID-19 tests
Health & Biotech
Check up: Diarrhoea and the FDA are lifting share prices
News
+70pc of small cap raises from April are currently trading above their offer price
Health & Biotech
Going Viral: All the best COVID-19 news from the week
News
The number of domestic ASX-listed companies is at 13yr lows. That’s not necessarily a bad thing
Health & Biotech
Dr Boreham’s Crucible: A simpler device gives Atomo the upper hand in blood-based diagnostics
Experts
ScoPo’s health powerplays: How to invest in COVID-19
News
Trading Places: Check out the latest stock WiseTech’s Michael Gregg has been buying
News
